Biotage AB Statistics

Total Valuation

Biotage AB has a market cap or net worth of 1.20 billion. The enterprise value is 1.18 billion.

Market Cap	1.20B
Enterprise Value	1.18B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	80.05M
Shares Outstanding	n/a
Shares Change (YoY)	+3.44%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	61.67M

Valuation Ratios

The trailing PE ratio is 47.21 and the forward PE ratio is 47.76.

PE Ratio	47.21
Forward PE	47.76
PS Ratio	6.14
PB Ratio	3.13
P/TBV Ratio	12.69
P/FCF Ratio	45.61
P/OCF Ratio	34.60
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.19, with an EV/FCF ratio of 44.88.

EV / Earnings	46.46
EV / Sales	5.72
EV / EBITDA	23.19
EV / EBIT	33.51
EV / FCF	44.88

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.06.

Current Ratio	2.53
Quick Ratio	1.53
Debt / Equity	0.06
Debt / EBITDA	0.49
Debt / FCF	0.90
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 6.59% and return on invested capital (ROIC) is 5.09%.

Return on Equity (ROE)	6.59%
Return on Assets (ROA)	4.25%
Return on Invested Capital (ROIC)	5.09%
Return on Capital Employed (ROCE)	7.91%
Revenue Per Employee	314,086
Profits Per Employee	40,842
Employee Count	680
Asset Turnover	0.40
Inventory Turnover	1.66

Taxes

In the past 12 months, Biotage AB has paid 3.49 million in taxes.

Income Tax	3.49M
Effective Tax Rate	12.07%

Stock Price Statistics

The stock price has increased by +1.64% in the last 52 weeks. The beta is 0.85, so Biotage AB's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+1.64%
50-Day Moving Average	15.89
200-Day Moving Average	n/a
Relative Strength Index (RSI)	51.20
Average Volume (20 Days)	636

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotage AB had revenue of 195.36 million and earned 25.40 million in profits. Earnings per share was 0.32.

Revenue	195.36M
Gross Profit	122.34M
Operating Income	33.37M
Pretax Income	28.89M
Net Income	25.40M
EBITDA	45.13M
EBIT	33.37M
Earnings Per Share (EPS)	0.32

Full Income Statement

Balance Sheet

The company has 41.84 million in cash and 23.71 million in debt, giving a net cash position of 18.13 million.

Cash & Cash Equivalents	41.84M
Total Debt	23.71M
Net Cash	18.13M
Net Cash Per Share	n/a
Equity (Book Value)	383.15M
Book Value Per Share	4.79
Working Capital	72.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.67 million and capital expenditures -8.37 million, giving a free cash flow of 26.30 million.

Operating Cash Flow	34.67M
Capital Expenditures	-8.37M
Free Cash Flow	26.30M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.62%, with operating and profit margins of 17.08% and 13.00%.

Gross Margin	62.62%
Operating Margin	17.08%
Pretax Margin	14.79%
Profit Margin	13.00%
EBITDA Margin	23.10%
EBIT Margin	17.08%
FCF Margin	13.46%

Dividends & Yields

Biotage AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	50.20%
Buyback Yield	-3.44%
Shareholder Yield	n/a
Earnings Yield	2.12%
FCF Yield	2.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotage AB has an Altman Z-Score of 10.32 and a Piotroski F-Score of 6.

Altman Z-Score	10.32
Piotroski F-Score	6